INCYTE CORP - 8-K Filing
Incyte Corp cancels planned Phase 3 MAESTRA-3 study for INCB123667 in ovarian cancer (Items: 8.01 Other Events)
Tickers: $INCY
More Regulatory news
- Andersen Group Inc. - 8-K Filing
- AltEnergy Acquisition Corp - 10-Q Filing
- AtlasClear Holdings, Inc. - 10-Q Filing
- Amerant Bancorp Inc. - 8-K Filing
- iShares Gold Trust Micro - 8-K Filing
- iShares Silver Trust - 8-K Filing
- ISHARES GOLD TRUST - 8-K Filing
- Tradewinds Universal - 8-K Filing
- iShares Bitcoin Trust ETF - 8-K Filing
- iShares S&P GSCI Commodity-Indexed Trust - 8-K Filing